Literature DB >> 30847194

A child with Klinefelter syndrome and both IgE-mediated food allergy and low proportion of naive Treg.

Rachel Frederick1, Peter Vuillermin1,2,3, Mimi L K Tang3, Anne-Louise Ponsonby3, Elise Webster1, Richard Saffery3, Fiona Collier1,2,3,4.   

Abstract

This case suggests a possible association between Klinefelter Syndrome and decreased regulatory T cells (Treg) cells, relating to an increased risk of allergic and autoimmune disorders in these patients. The immune phenotyping of the circulating FOXP3+ naive Treg populations in KS patients may help to indicate this predisposition.

Entities:  

Keywords:  FoxP3; Klinefelter syndrome; regulatory T cell

Year:  2019        PMID: 30847194      PMCID: PMC6389460          DOI: 10.1002/ccr3.1928

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Klinefelter syndrome (KS) is the most common male sex aneuploidy. It comprises one or more additional X chromosomes, typified by a karyotype of 47 XXY, with an incidence of 1 in 500‐1000 male births.1 Other variants, 48 XXXY or 49 XXXXY, occur but are less common and associated with a more extreme phenotype.1 The diagnosis of the 47 XXY form of KS is often delayed, and tends to present with tall stature, hypogonadism, infertility, and gynaecomastia.1 KS is associated with increased risk of autoimmune diseases such as systemic lupus erythematosus, scleroderma, polymyositis, and rheumatoid arthritis.2 The association between KS and atopy is less well characterised, but there appear to be higher rates of asthma and allergy, particularly in those with the more extreme forms of KS.3 Allergic and autoimmune conditions are linked to a breakdown in immune tolerance, and deficits in regulatory T‐cell (Treg) number and/or function have been associated with these conditions.4 The development and function of Treg is specified by transcriptional, epigenetic, and post‐transcriptional regulation of the FOXP3 gene, located on the X chromosome.5 Although the X chromosome polypoidy associated with KS has been linked to epigenetic and transcriptional dysregulation,6 it is unclear whether the expression of FOXP3 is disrupted in KS, and whether potential abnormality in Treg development and function contribute to the increased risk in autoimmune and allergic conditions associated with this syndrome.5 Here we describe a male child with IgE‐mediated food allergy and an exceptionally low proportion of FOXP3+ naïve Treg (nTreg) at 1 year of age, who was subsequently diagnosed with KS. The child was a participant in the Barwon Infant Study (BIS), which is an Australian birth cohort study (n = 1074), in which participants were recruited using an unselected antenatal sampling frame.7 The infant had no family history of food allergy or atopy. Both the perinatal and postnatal periods were uneventful. As part of the BIS protocol, at 1 year he was found to have a 3‐mm positive reaction to egg and clinical allergy was confirmed using a validated food challenge protocol.7 He remained food allergic at 4 years of age. He also had a clinical diagnosis of eczema, and has an extensive history of viral infections. In the context of speech delay, karyotype testing was conducted at 2 years, revealing a 48, XXXY chromosomal structure/pattern. Mild impairments to fine and gross motor skills, as well as motor dyspraxia, were subsequently attributed to this diagnosis. As an additional component of the BIS protocol, immune phenotyping of the circulating nTreg populations was also performed at 1 year of age.8 Notably, the proportion of nTreg (as a proportion of total CD4+ T‐cells) was found to be 1.35% ‐ the lowest of the 675 individual infants in BIS who underwent nTreg measures (Figure 1).
Figure 1

Distribution of nTreg at one year of age among participants in the Barwon Infant Study. Peripheral blood samples were collected at one year of age and the mononuclear cells (MNC) isolated. The proportion of naïve Treg (nTreg, CD4+/CD45RA+/FoxP3+) was measured by flow cytometry and presented as a percentage of the CD4+ T cells (mean = 5.53% (95% CI, 5.40%‐5.65%), n = 675). The infant who was later diagnosed with Klinefelter syndrome had the lowest percentage of nTreg (1.35%)

Distribution of nTreg at one year of age among participants in the Barwon Infant Study. Peripheral blood samples were collected at one year of age and the mononuclear cells (MNC) isolated. The proportion of naïve Treg (nTreg, CD4+/CD45RA+/FoxP3+) was measured by flow cytometry and presented as a percentage of the CD4+ T cells (mean = 5.53% (95% CI, 5.40%‐5.65%), n = 675). The infant who was later diagnosed with Klinefelter syndrome had the lowest percentage of nTreg (1.35%) There are currently no reports of the frequency of nTreg in KS. Investigations of Treg measures have been performed in Turners syndrome, a 45,X karyotype; however no changes in frequency were observed.9 KS is associated with variable inactivation of the surplus X chromosome(s),1 and differential expression of a number of X‐chromosomal genes has been reported.10 Our data support a link between the atypical copy number of FOXP3 in KS, a decrease in nTreg, and an increased risk of allergic disease. Further studies regarding FOXP3 methylation and/or gene expression in KS and its variants are required and may inform the care and monitoring of KS patients.

CONFLICT OF INTEREST

The authors have no conflicts of interest.

AUTHOR CONTRIBUTION

RF: original draft; PV: draft review and edit, management of clinical case; MLKT: draft review and edit; ALP: draft review and edit; EW: draft review and edit; RS: draft review and edit; FC: investigation, methodology, original draft, draft review and edit; the Barwon Infant Study Investigator (BIS) Group ‐ oversight of BIS cohort study.
  10 in total

Review 1.  Epigenetic and transcriptional control of Foxp3+ regulatory T cells.

Authors:  Jochen Huehn; Marc Beyer
Journal:  Semin Immunol       Date:  2015-03-20       Impact factor: 11.130

2.  Cohort Profile: The Barwon Infant Study.

Authors:  Peter Vuillermin; Richard Saffery; Katrina J Allen; John B Carlin; Mimi L K Tang; Sarath Ranganathan; David Burgner; Terry Dwyer; Fiona Collier; Kim Jachno; Peter Sly; Christos Symeonides; Kathleen McCloskey; John Molloy; Michael Forrester; Anne-Louise Ponsonby
Journal:  Int J Epidemiol       Date:  2015-03-30       Impact factor: 7.196

3.  Gene expression patterns in relation to the clinical phenotype in Klinefelter syndrome.

Authors:  Michael Zitzmann; Rebecca Bongers; Steffi Werler; Nadja Bogdanova; Joachim Wistuba; Sabine Kliesch; Jörg Gromoll; Frank Tüttelmann
Journal:  J Clin Endocrinol Metab       Date:  2014-12-22       Impact factor: 5.958

Review 4.  Klinefelter syndrome: clinical and molecular aspects.

Authors:  Jacques C Giltay; Merel C Maiburg
Journal:  Expert Rev Mol Diagn       Date:  2010-09       Impact factor: 5.225

Review 5.  Advances in the Interdisciplinary Care of Children with Klinefelter Syndrome.

Authors:  Shanlee Davis; Susan Howell; Rebecca Wilson; Tanea Tanda; Judy Ross; Philip Zeitler; Nicole Tartaglia
Journal:  Adv Pediatr       Date:  2016-08

6.  Food-allergic infants have impaired regulatory T-cell responses following in vivo allergen exposure.

Authors:  Thanh D Dang; Katrina J Allen; David J Martino; Jennifer J Koplin; Paul V Licciardi; Mimi L K Tang
Journal:  Pediatr Allergy Immunol       Date:  2015-11-23       Impact factor: 6.377

Review 7.  Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes.

Authors:  Amr H Sawalha; John B Harley; R Hal Scofield
Journal:  J Autoimmun       Date:  2009-05-22       Impact factor: 7.094

8.  The ontogeny of naïve and regulatory CD4(+) T-cell subsets during the first postnatal year: a cohort study.

Authors:  Fiona M Collier; Mimi L K Tang; David Martino; Richard Saffery; John Carlin; Kim Jachno; Sarath Ranganathan; David Burgner; Katrina J Allen; Peter Vuillermin; Anne-Louise Ponsonby
Journal:  Clin Transl Immunology       Date:  2015-03-27

9.  Epigenomic and transcriptomic signatures of a Klinefelter syndrome (47,XXY) karyotype in the brain.

Authors:  Joana Viana; Ruth Pidsley; Claire Troakes; Helen Spiers; Chloe Cy Wong; Safa Al-Sarraj; Ian Craig; Leonard Schalkwyk; Jonathan Mill
Journal:  Epigenetics       Date:  2014-01-29       Impact factor: 4.528

10.  CD4+ FOXP3+ Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome.

Authors:  Young Ah Lee; Hang-Rae Kim; Jeong Seon Lee; Hae Woon Jung; Hwa Young Kim; Gyung Min Lee; Jieun Lee; Ji Hyun Sim; Sae Jin Oh; Doo Hyun Chung; Choong Ho Shin; Sei Won Yang
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.